Emcure Pharmaceuticals Statistics
Total Valuation
NSE:EMCURE has a market cap or net worth of INR 195.11 billion. The enterprise value is 206.52 billion.
Market Cap | 195.11B |
Enterprise Value | 206.52B |
Important Dates
The next estimated earnings date is Tuesday, May 27, 2025.
Earnings Date | May 27, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
NSE:EMCURE has 189.48 million shares outstanding. The number of shares has increased by 2.25% in one year.
Current Share Class | n/a |
Shares Outstanding | 189.48M |
Shares Change (YoY) | +2.25% |
Shares Change (QoQ) | +0.51% |
Owned by Insiders (%) | 72.91% |
Owned by Institutions (%) | 3.11% |
Float | 20.38M |
Valuation Ratios
The trailing PE ratio is 31.34 and the forward PE ratio is 23.21. NSE:EMCURE's PEG ratio is 0.89.
PE Ratio | 31.34 |
Forward PE | 23.21 |
PS Ratio | 2.58 |
PB Ratio | 4.53 |
P/TBV Ratio | 6.26 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | 0.89 |
Enterprise Valuation
EV / Earnings | 33.99 |
EV / Sales | 2.74 |
EV / EBITDA | 15.35 |
EV / EBIT | 20.40 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.28 |
Debt / EBITDA | 0.88 |
Debt / FCF | n/a |
Interest Coverage | 6.33 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 6.96M |
Profits Per Employee | 559,844 |
Employee Count | 10,852 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 1,007.05 |
200-Day Moving Average | n/a |
Relative Strength Index (RSI) | 50.65 |
Average Volume (20 Days) | 178,514 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:EMCURE had revenue of INR 75.51 billion and earned 6.08 billion in profits. Earnings per share was 32.85.
Revenue | 75.51B |
Gross Profit | 45.65B |
Operating Income | 10.12B |
Pretax Income | 8.78B |
Net Income | 6.08B |
EBITDA | 13.06B |
EBIT | 10.12B |
Earnings Per Share (EPS) | 32.85 |
Balance Sheet
The company has 2.32 billion in cash and 11.89 billion in debt, giving a net cash position of -9.56 billion or -50.47 per share.
Cash & Cash Equivalents | 2.32B |
Total Debt | 11.89B |
Net Cash | -9.56B |
Net Cash Per Share | -50.47 |
Equity (Book Value) | 43.03B |
Book Value Per Share | 218.65 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 60.46%, with operating and profit margins of 13.41% and 8.05%.
Gross Margin | 60.46% |
Operating Margin | 13.41% |
Pretax Margin | 11.62% |
Profit Margin | 8.05% |
EBITDA Margin | 17.29% |
EBIT Margin | 13.41% |
FCF Margin | n/a |
Dividends & Yields
NSE:EMCURE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -2.25% |
Shareholder Yield | -2.25% |
Earnings Yield | 3.11% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |